SECTION 71 ACCEPTED
on 01 May 2024
Last Applicant/ Owned by
Chiyoda-ku
Tokyo
JP
100-0005
Serial Number
79071477 filed on 13th Mar 2009
Registration Number
4398169 registered on 10th Sep 2013
Correspondent Address
Mainak H. Mehta
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
SEIKAGAKU CORPORATION
[ Injection syringes; Injection needles; Ophthalmic and intra-articular applicators for pharmaceutical preparations ] [ Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; ] Chondroitin sulfate and salts of ch Read More
Classification Information
Class [010]
Medical Instrument Products
[ Injection syringes; Injection needles; Ophthalmic and intra-articular applicators for pharmaceutical preparations ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Joint function improving agents, namely, pharmaceutical preparations for treating arthrosis and other joint diseases; [ ophthalmic surgical aid, namely, sodium hyaluronate solution used for surgery in and around the eyes; Submucosal injection materials for endoscopes used for the treatment of dissecting and resecting tumors and cancer, namely, submucosal injectable preparations for treatment of dissecting and resecting tumors and cancer; Pharmaceutical preparations for the treatment of disc hernia; ] Syringes sold filled with crosslinked or non-crosslinked hyaluronic acid based gel; Syringes sold filled with sodium hyaluronate solutions [ ; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposes, namely, diagnostic reagents for in-vitro clinical diagnostic purposes ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
[ Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; ] Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of pharmaceutical preparations, [ cosmetic preparations, food, nutritional supplements and ] biomaterials, and for research purposes in the biomedical field; Chemical reagents for scientific, research and quality control purposes, namely, limulus amebocyte lysate reagents for use in analysis of endotoxins [ and beta-glucan ] ; Reagents for scientific medical research and quality control testing use, namely, for use in determining the presence of analytes in or on water, pharmaceutical products, medical devices, dialysate, blood, blood components, body fluids, and tissues; Reagents for clinical or medical laboratory use, namely, glycobiological analysis reagents and diagnostic preparations and reagents for clinical or medical laboratory use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79071477
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 120776SKG006
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Jan 2025 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 01st May 2024 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| 01st May 2024 | REGISTERED-SEC.71 ACCEPTED |
| 23rd Apr 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 29th Aug 2023 | TEAS SECTION 71 RECEIVED |
| 10th Sep 2022 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| 25th Dec 2021 | PARTIAL INVALIDATION PROCESSED BY THE IB |
| 14th Nov 2021 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 14th Nov 2021 | INVALIDATION PROCESSED |
| 24th Oct 2021 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |